Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Nov 14, 2025 3:59:52 PM EST

15.89USD-1.610%(-0.26)444,724

0.00Bid 0.00Ask 0.00Spread

Pre-market

Nov 14, 2025 9:28:30 AM EST

15.55USD-3.715%(-0.60)18,534

After-hours

Nov 14, 2025 4:25:30 PM EST

16.09USD+1.259%(+0.20)2,275

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

187.13M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

589,700

Avg. Vol. 30 Day

739,334

Employees

Market Cap

187,129,252

Shares Out.

11,776,542

On/Off Exchange

39%/61%

6 Month Beta

4.51

1 Year Beta

0.99

2 Year Beta

1.19

3 Year Beta

1.14

52 Week Low

6.76

52 Week High

130.00

SMA50

21.93

SMA200

26.37

1 Week

-5.70%

1 Month

-15.52%

3 Month

-69.06%

6 Month

-43.25%

1 Year

+21.21%

2 Year

-98.94%

5 Year

-100.00%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $15.89, and today's volume is 444,724. TNXP is down -1.610% today. The 30 day average volume is 739,334. TNXP market cap is 187.13M with 11,776,542 shares outstanding.